Reversal of vascular and renal crises of scleroderma by oral angiotensin-converting-enzyme blockade.
D000328:Adult; D000806:Angiotensin-Converting Enzyme Inhibitors; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000209:etiology; D007674:Kidney Diseases / Q000188:drug therapy* / Q000209:etiology; D008297:Male; D011392:Proline / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D012083:Renin / Q000097:blood; D012595:Scleroderma, Systemic / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D014657:Vasculitis / Q000188:drug therapy / Q000209:etiology
D000806:Angiotensin-Converting Enzyme Inhibitors; D011392:Proline; D012083:Renin